Abstract:Photoresponsive ruthenium (Ru) complexes have been extensively studied in the photodynamic therapy (PDT) of cancer. The metal-to-ligand charge transfer (MLCT) absorption maximum of most Ru complexes is located in the short-wavelength visible region, which is well suited for superficial tumors but shows inefficient therapeutic effects for more deep-seated ones. Moreover, Ru complexes are primarily located in the mitochondria or nucleus, always resulting in high levels of dark toxicity and DNA mutation. Herein, we reported a new ruthenium complex (Ru-I) for red-light-triggered PDT. The activation wavelength of Ru-I is successfully extended to 660 nm. Importantly, the complex photosensitizer can be quickly taken up by cancer cells and selectively accumulated in the lysosome, an ideal localization for PDT purposes. Intratumoral injection of Ru-I into tumor-bearing mice achieved excellent therapeutic effects and thus holds great promise for applications in lysosome localization photodynamic therapy.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c22551?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c22551</a>.Experimental details including synthetic methods of Ru-I and characterization; ESI-HRMS spectrum of compound 3 (Figure S1); 1H NMR spectrum of compound 3 (Figure S2); ESI-HRMS spectrum of compound 4 (Figure S3); 1H NMR and 13C NMR spectra of compound 4 (Figure S4); purity of Ru-I measurement by HPLC (Figure S5); HOMO and LUMO orbitals for Ru-I (Figure S6); absorption and emission spectrum of Ru-I in different solvents (Figure S7); stability of Ru-I with different treatments (Figures S8 and S9); ROS generation analysis (Figures S10–S12); cell imaging experiments (Figures S13–S17); in vitro photocytotoxicity evaluation (Figures S18–S20); and animal experiments (Figures S21 and S22) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c22551/suppl_file/am0c22551_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Rational design of a lysosome-targeting and near-infrared absorbing Ru( ii )–BODIPY conjugate for photodynamic therapy

Highly Efficient Far-Red/NIR-Absorbing Neutral Ir(III) Complex Micelles for Potent Photodynamic/Photothermal Therapy

Engineering Lysosome-Targeting BODIPY Nanoparticles for Photoacoustic Imaging and Photodynamic Therapy under Near-Infrared Light.

Rational design of iridium-porphyrin conjugates for novel synergistic photodynamic and photothermal therapy anticancer agents

Biocompatible conjugated porphyrin nanoparticles with photodynamic/photothermal performances in cancer therapy

A Near-Infrared and Lysosome-Targeted Coumarin-Bodipy Photosensitizer for Photodynamic Therapy Against HepG2 Cells

Three Near-Infrared and Lysosome-Targeting Probes for Photodynamic Therapy (PDT).

Designing NIR AIEgens for lysosomes targeting and efficient photodynamic therapy of tumors

Red-Light-Responsive Ru Complex Photosensitizer for Lysosome Localization Photodynamic Therapy

Lysosome Targeting Bis-terpyridine Ruthenium(II) Complexes: Photophysical Properties and in Vitro Photodynamic Therapy.

NIR-Absorbing Tetraphenylethene-Containing bisBODIPY Nanoplatforms Demonstrate Effective Lysosome-Targeting and Combinational Phototherapy

A Second Near-Infrared Ru(II) Polypyridyl Complex for Synergistic Chemo-Photothermal Therapy

An oxygen-carrying and lysosome-targeting BODIPY derivative for NIR bioimaging and enhanced multimodal therapy against hypoxic tumors

Lysosome-targeted Cyclometalated Ir(III) Complexes as Photosensitizer/Photoredox Catalysis for Cancer Therapy

Uridine-Modified Ruthenium(II) Complex as Lysosomal LIMP-2 Targeting Photodynamic Therapy Photosensitizer for the Treatment of Triple-Negative Breast Cancer

Bithiophene‐Functionalized Infrared Two‐Photon Absorption Metal Complexes as Single‐Molecule Platforms for Synergistic Photodynamic, Photothermal, and Chemotherapy

Lysosome-targeted Aza-BODIPY Photosensitizers for Anti-Cancer Photodynamic Therapy

pH-Sensitive and Lysosome Targetable Photosensitizers Based on BODIPYs

Discovery of Subcellular-Targeted Aza-BODIPY Photosensitizers for Efficient Photodynamic Antitumor Therapy.

A Cyanine-based Liposomal Nanophotosensitizer for Enhanced Cancer Chemo-Photodynamic Therapy

Lysosome directed red light photodynamic therapy using glycosylated iron-(III) conjugates of boron-dipyrromethene